Medical - Healthcare Information Services
Compare Stocks
2 / 10Stock Comparison
ONMD vs NVDA
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
ONMD vs NVDA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Healthcare Information Services | Semiconductors |
| Market Cap | $32M | $5.05T |
| Revenue (TTM) | $1M | $215.94B |
| Net Income (TTM) | $-3M | $120.07B |
| Gross Margin | -37.0% | 71.1% |
| Operating Margin | -7.1% | 60.4% |
| Forward P/E | — | 25.1x |
| Total Debt | $570K | $11.41B |
| Cash & Equiv. | $585K | $10.61B |
ONMD vs NVDA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 21 | May 26 | Return |
|---|---|---|---|
| OneMedNet Corporati… (ONMD) | 100 | 9.7 | -90.3% |
| NVIDIA Corporation (NVDA) | 100 | 1038.3 | +938.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ONMD vs NVDA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ONMD carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 0.37
- Rev growth 111.4%, EPS growth 83.3%, 3Y rev CAGR 5.6%
- Lower volatility, beta 0.37, current ratio 0.43x
NVDA is the clearest fit if your priority is long-term compounding.
- 234.3% 10Y total return vs ONMD's -90.3%
- 55.6% margin vs ONMD's -206.1%
- 0.0% yield; 2-year raise streak; the other pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 111.4% revenue growth vs NVDA's 65.5% | |
| Quality / Margins | 55.6% margin vs ONMD's -206.1% | |
| Stability / Safety | Beta 0.37 vs NVDA's 1.73 | |
| Dividends | 0.0% yield; 2-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +134.4% vs NVDA's +82.9% | |
| Efficiency (ROA) | 58.1% ROA vs ONMD's -145.0% |
ONMD vs NVDA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ONMD vs NVDA — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
NVDA leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NVDA is the larger business by revenue, generating $215.9B annually — 158894.8x ONMD's $1M. NVDA is the more profitable business, keeping 55.6% of every revenue dollar as net income compared to ONMD's -2.1%. On growth, ONMD holds the edge at +33.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1M | $215.9B |
| EBITDAEarnings before interest/tax | -$10M | $133.2B |
| Net IncomeAfter-tax profit | -$3M | $120.1B |
| Free Cash FlowCash after capex | -$8M | $96.7B |
| Gross MarginGross profit ÷ Revenue | -37.0% | +71.1% |
| Operating MarginEBIT ÷ Revenue | -7.1% | +60.4% |
| Net MarginNet income ÷ Revenue | -2.1% | +55.6% |
| FCF MarginFCF ÷ Revenue | -5.5% | +44.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +33.2% | +73.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +26.3% | +97.8% |
Valuation Metrics
ONMD leads this category, winning 2 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $32M | $5.05T |
| Enterprise ValueMkt cap + debt − cash | $31M | $5.05T |
| Trailing P/EPrice ÷ TTM EPS | -16.02x | 42.38x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 25.09x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.44x |
| EV / EBITDAEnterprise value multiple | — | 37.89x |
| Price / SalesMarket cap ÷ Revenue | 23.18x | 23.37x |
| Price / BookPrice ÷ Book value/share | — | 32.26x |
| Price / FCFMarket cap ÷ FCF | — | 52.21x |
Profitability & Efficiency
ONMD leads this category, winning 3 of 5 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), ONMD scores 5/9 vs NVDA's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | — | +76.3% |
| ROA (TTM)Return on assets | -145.0% | +58.1% |
| ROICReturn on invested capital | — | +81.8% |
| ROCEReturn on capital employed | — | +97.2% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 |
| Debt / EquityFinancial leverage | — | 0.07x |
| Net DebtTotal debt minus cash | -$15,000 | $807M |
| Cash & Equiv.Liquid assets | $585,000 | $10.6B |
| Total DebtShort + long-term debt | $570,000 | $11.4B |
| Interest CoverageEBIT ÷ Interest expense | -40.79x | 545.03x |
Total Returns (Dividends Reinvested)
NVDA leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NVDA five years ago would be worth $143,108 today (with dividends reinvested), compared to $971 for ONMD. Over the past 12 months, ONMD leads with a +134.4% total return vs NVDA's +82.9%. The 3-year compound annual growth rate (CAGR) favors NVDA at 92.4% vs ONMD's -55.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -21.2% | +10.0% |
| 1-Year ReturnPast 12 months | +134.4% | +82.9% |
| 3-Year ReturnCumulative with dividends | -91.1% | +612.7% |
| 5-Year ReturnCumulative with dividends | -90.3% | +1331.1% |
| 10-Year ReturnCumulative with dividends | -90.3% | +23433.1% |
| CAGR (3Y)Annualised 3-year return | -55.3% | +92.4% |
Risk & Volatility
Evenly matched — ONMD and NVDA each lead in 1 of 2 comparable metrics.
Risk & Volatility
ONMD is the less volatile stock with a 0.37 beta — it tends to amplify market swings less than NVDA's 1.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVDA currently trades 95.8% from its 52-week high vs ONMD's 22.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.37x | 1.73x |
| 52-Week HighHighest price in past year | $4.22 | $216.80 |
| 52-Week LowLowest price in past year | $0.31 | $110.82 |
| % of 52W HighCurrent price vs 52-week peak | +22.8% | +95.8% |
| RSI (14)Momentum oscillator 0–100 | 53.3 | 50.8 |
| Avg Volume (50D)Average daily shares traded | 5.2M | 166.2M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $278.83 |
| # AnalystsCovering analysts | — | 79 |
| Dividend YieldAnnual dividend ÷ price | — | +0.0% |
| Dividend StreakConsecutive years of raises | — | 2 |
| Dividend / ShareAnnual DPS | — | $0.04 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.8% |
NVDA leads in 2 of 6 categories (Income & Cash Flow, Total Returns). ONMD leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.
ONMD vs NVDA: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is ONMD or NVDA a better buy right now?
For growth investors, OneMedNet Corporation (ONMD) is the stronger pick with 111.
4% revenue growth year-over-year, versus 65. 5% for NVIDIA Corporation (NVDA). NVIDIA Corporation (NVDA) offers the better valuation at 42. 4x trailing P/E (25. 1x forward), making it the more compelling value choice. Analysts rate NVIDIA Corporation (NVDA) a "Buy" — based on 79 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — ONMD or NVDA?
Over the past 5 years, NVIDIA Corporation (NVDA) delivered a total return of +1331%, compared to -90.
3% for OneMedNet Corporation (ONMD). Over 10 years, the gap is even starker: NVDA returned +234. 3% versus ONMD's -90. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — ONMD or NVDA?
By beta (market sensitivity over 5 years), OneMedNet Corporation (ONMD) is the lower-risk stock at 0.
37β versus NVIDIA Corporation's 1. 73β — meaning NVDA is approximately 362% more volatile than ONMD relative to the S&P 500.
04Which is growing faster — ONMD or NVDA?
By revenue growth (latest reported year), OneMedNet Corporation (ONMD) is pulling ahead at 111.
4% versus 65. 5% for NVIDIA Corporation (NVDA). On earnings-per-share growth, the picture is similar: OneMedNet Corporation grew EPS 83. 3% year-over-year, compared to 66. 7% for NVIDIA Corporation. Over a 3-year CAGR, NVDA leads at 100. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — ONMD or NVDA?
NVIDIA Corporation (NVDA) is the more profitable company, earning 55.
6% net margin versus -206. 1% for OneMedNet Corporation — meaning it keeps 55. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVDA leads at 60. 4% versus -711. 3% for ONMD. At the gross margin level — before operating expenses — NVDA leads at 71. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — ONMD or NVDA?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is ONMD or NVDA better for a retirement portfolio?
For long-horizon retirement investors, OneMedNet Corporation (ONMD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
37)). NVIDIA Corporation (NVDA) carries a higher beta of 1. 73 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ONMD: -90. 3%, NVDA: +234. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between ONMD and NVDA?
These companies operate in different sectors (ONMD (Healthcare) and NVDA (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.